Related Experiment Videos
[Infections and antibiotic prophylaxis in sickle cell disease]
Ph Lepage1, M F Dresse, P Forget
1Département Universitaire de Pédiatrie, CHU-CHR, ULg, Liège. philippe.lepage@chrcitadelle.be
Revue Medicale De Liege
|May 14, 2004
Summary
Children with sickle cell disease face high risks of bacterial infections, particularly from pneumococci and salmonellae. Early antibiotic prophylaxis and vaccination are crucial for preventing severe illness and mortality.
Area of Science:
- Pediatric Infectious Diseases
- Hematology
- Immunology
Context:
- Bacterial infections are a leading cause of illness and death in young children with sickle cell disease (SCD).
- Homozygous SCD (HbSS) and SC hemoglobinopathy present increased susceptibility to bacteremia, with higher incidence rates in children under three years old.
- Common pathogens include Streptococcus pneumoniae and Salmonella species, leading to severe conditions like septicemia, meningitis, osteomyelitis, and pneumonia.
Purpose:
- To highlight the significant risk of bacterial infections in children with sickle cell disease.
- To emphasize the severity of these infections and their impact on morbidity and mortality.
- To underscore the importance of preventive strategies such as antibiotic prophylaxis and vaccination.
Summary:
- Children with sickle cell disease experience a high incidence of bacteremia, with rates of approximately 8 and S events/100 patient-years in homozygous SCD and SC hemoglobinopathy, respectively, under age three.
- Key bacterial culprits are Pneumococci and Salmonellae, often causing severe manifestations including septicemia, meningitis, osteomyelitis, and pneumonia.
- Infections with Mycoplasma pneumoniae and Chlamydia pneumoniae can also be severe, potentially leading to acute chest syndrome.
Impact:
- The high burden of bacterial infections in pediatric SCD necessitates proactive prevention measures.
- Oral penicillin prophylaxis, recommended from three months of age, is effective against pneumococcal infections.
- Antipneumococcal conjugate vaccines are safe and immunogenic in infants, offering crucial protection.